Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950135-09-001657
Filing Date
2009-03-11
Accepted
2009-03-11 07:01:34
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 IDERA PHARMACEUTICALS, INC. b73456ipe10vk.htm 10-K 1095594
2 EX-10.38 AMENDMENT TO THE CONSULTING SERVICES AGREEMENT b73456ipexv10w38.htm EX-10.38 7883
3 EX-10.55 AMENDMENT TO THE LICENSE AGREEMENT b73456ipexv10w55.htm EX-10.55 50046
4 EX-23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM b73456ipexv23w1.htm EX-23.1 1790
5 EX-31.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b73456ipexv31w1.htm EX-31.1 8217
6 EX-31.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER b73456ipexv31w2.htm EX-31.2 8210
7 EX-32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1 b73456ipexv32w1.htm EX-32.1 3070
8 EX-32.2 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1 b73456ipexv32w2.htm EX-32.2 3545
  Complete submission text file 0000950135-09-001657.txt   1179847
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31918 | Film No.: 09671156
SIC: 2836 Biological Products, (No Diagnostic Substances)